UnknownNCT03312712

Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation

Studying Hypersensitivity pneumonitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cambridge University Hospitals NHS Foundation Trust
Principal Investigator
Joseph Cheriyan, MBChB, MA, FRCP
Cambridge University Hospitals NHS Foundation Trust
Intervention
PET/CT scan(radiation)
Enrollment
36 enrolled
Eligibility
30 years · All sexes
Timeline
2018 – 2022

Study locations (2)

Collaborators

GlaxoSmithKline

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03312712 on ClinicalTrials.gov

Other trials for Hypersensitivity pneumonitis

Additional recruiting or active studies for the same condition.

See all trials for Hypersensitivity pneumonitis →

← Back to all trials